Role of apoptosis in amplifying inflammatory responses in lung diseases

Journal of Cell Death

Volumn 2010, Issue , 2010, Pages 41-53

  Schmidt, E P ^a,b   Tuder, R M ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Acute lung injury; Chronic obstructive pulmonary disease; Damage associated molecular patterns; Damps; Danger signaling; Efferocytosis; Pattern receptors

Indexed keywords

EID: 80054969912     PISSN: None     EISSN: 11790660     Source Type: Journal    
DOI: 10.4137/jcd.s5375     Document Type: Review

References (152)

1. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and t{stroke}olerogenic cell death. Nat Rev Immunol. 2009;9(5):353-63.
2. Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest. 2006;129(6):1673-82.
3. Henson PM, Cosgrove GP, Vandivier RW. State of the Art. apoptosis and cell homeostasis in chronic obstructive pulmonary disease. Proc Am T{stroke}horac Soc. 2006;3(6):512-6.
4. Xu J, Zhang X, Pelayo R, et al. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009;15(11):1318-21.
5. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104-7.
6. Eckle T, Koeppen M, Eltzschig HK. Role of extracellular adenosine in acute lung injury. Physiology (Bethesda). 2009;24:298-306.
7. Jiang D, Liang J, Fan J, et al. Regulation of lung injury and repair by T{stroke}oll-like receptors and hyaluronan. Nat Med. 2005;11(11):1173-9.
8. Babelova A, Moreth K, Tsalastra-Greul W, et al. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem. 2009;284(36):24035-48.
9. Wheeler DS, Wong HR. Heat shock response and acute lung injury. Free Radic Biol Med. 2007;42(1):1-14.
10. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000;165(6):2950-4.
11. Schmidt R, Luboeinski T, Markart P, et al. Alveolar antioxidant status in patients with acute respiratory distress syndrome. Eur Respir J. 2004;24(6): 994-9.
12. Schneider DJ, Lindsay JC, Zhou Y, Molina JG, Blackburn MR. Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease. FASEB J. 2010;24(1):70-80.
13. Ferhani N, Letuve S, Kozhich A, et al. Expression of High-Mobility Group Box 1 and of Receptor for Advanced Glycation End Products in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2010;181(9): 917-27.
14. Garcia-Pachon E, Padilla-Navas I, Shum C. Serum uric acid to creatinine ratio in patients with chronic obstructive pulmonary disease. Lung. 2007; 185(1):21-4.
15. Borchers MT, Wesselkamper SC, Curull V, et al. Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. J Clin Invest. 2009;119(3):636-49.
16. Houghton AM, Quintero PA, Perkins DL, et al. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest. 2006; 116(3):753-9.
17. van Zoelen MAD, Ishizaka A, Wolthuis EK, Choi G, van der Poll T, Schultz MJ. Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia. [Miscellaneous article]. Shock. 2008;29(4):441-5.
18. Driver AG, Kukoly CA, Ali S, Mustafa SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis. 1993;148(1):91-7.
19. Monzon ME, Manzanares D, Schmid N, Casalino-Matsuda SM, Forteza RM. Hyaluronidase Expression and Activity Is Regulated by Pro-Inflammatory Cytokines in Human Airway Epithelial Cells. Am J Respir Cell Mol Biol. 2008;39(3):289-95.
20. Pini L, Hamid Q, Shannon J, et al. Differences in proteoglycan deposition in the airways of moderate and severe asthmatics. Eur Respir J. 2007; 29(1):71-7.
21. Tamasi L, Bohacs A, Tamasi V, et al. Increased circulating heat shock protein 70 levels in pregnant asthmatics. Cell Stress Chaperones. 2010; 15(3):295-300.
22. Chunn JL, Molina JG, Mi T, Xia Y, Kellems RE, Blackburn MR. Adenosine-Dependent Pulmonary Fibrosis in Adenosine Deaminase{Eth}eficient Mice. J Immunol. 2005;175(3):1937-46.
23. Venkatesan N, Ebihara T, Roughley PJ, Ludwig MS. Alterations in Large and Small Proteoglycans in Bleomycin-Induced Pulmonary Fibrosis in Rats. Am J Respir Crit Care Med. 2000;161(6):2066-73.
24. Ogawa F, Shimizu K, Hara T, et al. Serum levels of heat shock protein 70, a biomarker of cellular stress, are elevated in patients with systemic sclerosis: association with fibrosis and vascular damage. Clin Exp Rheumatol. 2008;26(4):659-62.
25. Hamada N, Maeyama T, Kawaguchi T, et al. The Role of High Mobility Group Box1in Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2008;39(4): 440-7.
26. Gasse P, Riteau N, Charron S, et al. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med. 2009;179(10):903-13.
27. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805-20.
28. Migeotte I, Communi D, Parmentier M. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev. 2006;17(6):501-19.
29. Palliser D. Unraveling the mechanisms by which heat shock proteins activate the immune system. Curr Opin Mol Ther. 2001;3(1):25-30.
30. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in Inflammation and Cancer. Annual Review of Immunology. 2010;28(1): 367-88.
31. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest. 2000;117(3):684-94.
32. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, et al. Inhibition of vascular endothelial growth factor receptors causes lung cell apoptosis and emphysema. J Clin Invest. 2000;106:1311-9.
33. Hogg JC. Why does airway inflammation persist after the smoking stops? Thorax. 2006;61(2):96-7.
34. Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunology and Cell Biology. 2003;81(4):289-96.
35. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med. 2009;360(23):2445-54.
36. MacNee W, Tuder RM. New paradigms in the pathogenesis of chronic obstructive pulmonary disease I. Proc Am Thorac Soc. 2009;6(6): 527-31.
37. Henson PM, Tuder RM. Apoptosis in the lung: induction, clearance and detection. AJP-Lung Cellular and Molecular Physiology. 2008;294(4): L601-11.
38. Yun JH, Henson PM, Tuder RM. Phagocytic clearance of apoptotic cells: role in lung disease. Expert Rev Resp Med. 2008;2(6):753-65.
39. Le A, Damico R, Damarla M, et al. Alveolar cell apoptosis is dependent on p38-MAPK-mediated activation of xanthine oxidoreductase in ventilator-induced lung injury. J Appl Physiol. 2008.
40. Borges VM, Vandivier RW, McPhillips KA, et al. TNFalpha inhibits apoptotic cell clearance in the lung, exacerbating acute inflammation. Am J Physiol Lung Cell Mol Physiol. 2009;297(4):L586-95.
41. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and Outcomes of Acute Lung Injury. N Engl J Med. 2005;353(16):1685-93.
42. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1334-49.
43. Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 2003;14(6): 523-35.
44. + Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest. 2009;119(10):2898-913.
45. Calfee CS, Matthay MA. Nonventilatory treatments for acute lung injury and ARDS. Chest. 2007;131(3):913-20.
46. Tang PS, Mura M, Seth R, Liu M. Acute lung injury and cell death: how many ways can cells die? Am J Physiol Lung Cell Mol Physiol. 2008; 294(4):L632-41.
47. Matute-Bello G, Liles WC, Steinberg KP, et al. Soluble Fas Ligand Induces Epithelial Cell Apoptosis in Humans with Acute Lung Injury (ARDS). J Immunol. 1999;163(4):2217-25.
48. Matsuda N, Yamamoto S, Takano K, et al. Silencing of fas-associated death domain protects mice from septic lung inflammation and apoptosis. Am J Respir Crit Care Med. 2009;179(9):806-15.
49. Kawasaki M, Kuwano K, Hagimoto N, et al. Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. Am J Pathol. 2000;157(2):597-603.
50. Rowe SJ, Allen L, Ridger VC, Hellewell PG, Whyte MK. Caspase1-deficient mice have delayed neutrophil apoptosis and a prolonged inflammatory response to lipopolysaccharide-induced acute lung injury. J Immunol. 2002;169(11):6401-7.
51. Pinheiro da SF, Nizet V. Cell death during sepsis: integration of disintegration in the inflammatory response to overwhelming infection. Apoptosis. 2009;14(4):509-21.
52. Gravante G, Delogu D, Sconocchia G. Systemic apoptotic response after thermal burns. Apoptosis. 2007;12(2):259-70.
53. Smith C, Kruger MJ, Smith RM, Myburgh KH. The inflammatory response to skeletal muscle injury: illuminating complexities. Sports Med. 2008; 38(11):947-69.
54. Czura CJ, Tracey KJ. Targeting high mobility group box 1 as a late-acting mediator of inflammation. [Review]. Critical Care Medicine. 2003; 31(1):S46-50.
55. Wang H, Bloom O, Zhang M, et al. HMG-1 as a Late Mediator of Endotoxin Lethality in Mice. Science. 1999;285(5425):248-51.
56. Kim JY, Park JS, Strassheim D, et al. HMGB1 contributes to the development of acute lung injury after hemorrhage. AJP-Lung Cellular and Molecular Physiology. 2005;288(5):L958-65.
57. Lutz W, Stetkiewicz J. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation. Int J Occup Med Environ Health. 2004;17(2):245-54.
58. Rock KL, Kono H. The inflammatory response to cell death. Annu Rev Pathol. 2008;3:99-126.
59. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418(6894):191-5.
60. Bell CW, Jiang W, Reich CF, III, Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol. 2006;291(6):C1318-25.
61. Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A. HMGB1: endogenous danger signaling. Mol Med. 2008;14(7-8):476-84.
62. Yamamoto TM, Ono TM, Ito TM, Yamanoi AM, Maruyama IM, Tanaka TM. Hemoperfusion with a high-mobility group box 1 adsorption column can prevent the occurrence of hepatic ischemia-reperfusion injury in rats*. [Article]. Critical Care Medicine. 2010;38(3):879-85.
63. Dong W, Cai B, Pena G, et al. Ethyl Pyruvate Prevents Inflammatory responses and Organ Damage During in Porcine Hemorrhage. Shock. 2009.
64. Kwon WY, Suh GJ, Kim KS, et al. Glutamine attenuates acute lung injury by inhibition of high mobility group box protein-1 expression during sepsis. Br J Nutr. 2010;103(6):890-8.
65. Hidaka S, Iwasaka H, Hagiwara S, Noguchi T. Gabexate Mesilate Inhibits the Expression of HMGB1 in Lipopolysaccharide-Induced Acute Lung Injury. J Surg Res. 2009.
66. Feng Y, Yang Q, Xu J, Qian G, Liu Y. Effects of HMGB1 on PMN apoptosis during LPS-induced acute lung injury. Experimental and Molecular Pathology. 2008;85(3):214-22.
67. Hagiwara S, Iwasaka H, Togo K, Noguchi T. A Neutrophil Elastase Inhibitor, Sivelestat, Reduces Lung Injury Following Endotoxin-Induced Shock in Rats by Inhibiting HMGB1. Inflammation. 2008;31(4):227-34.
68. Hagiwara S, Iwasaka H, Hasegawa A, Asai N, Noguchi T. High-dose intravenous immunoglobulin G improves systemic inflammation in a rat model of CLP-induced sepsis. Intensive Care Med. 2008;34(10): 1812-9.
69. Hagiwara S, Iwasaka H, Hidaka S, Hishiyama S, Noguchi T. Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats. Crit Care. 2008;12(2):R43.
70. Hagiwara S, Iwasaka H, Matsumoto S, Noguchi T. High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats. Intensive Care Medicine. 2008;34(2):361-7.
71. Hagiwara S, Iwasaka H, Noguchi T. Nafamostat mesilate inhibits the expression of HMGB1in lipopolysaccharide-induced acute lung injury. Journal of Anesthesia. 2007;21(2):164-70.
72. Suda K, Kitagawa Y, Ozawa S, et al. Anti-High-Mobility Group Box Chromosomal Protein 1Antibodies Improve Survival of Rats with Sepsis. World Journal of Surgery. 2006;30(9):1755-62.
73. Pan P, Cardinal J, Dhupar R, et al. Low-dose cisplatin administration in murine cecal ligation and puncture prevents the systemic release of HMGB1 and attenuates lethality. Journal of Leukocyte Biology. 2009; 86(3):625-32.
74. Yang ZY, Ling Y, Yin T, et al. Delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box 1 levels in rats. World J Gastroenterol. 2008;14(28):4546-50.
75. Yuan HM, Jin XM, Sun JM, et al. Protective Effect of HMGB1 A Box on Organ Injury of Acute Pancreatitis in Mice. [Article]. Pancreas. 2009; 38(2):143-8.
76. Sawa H, Ueda T, Takeyama Y, et al. Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. World J Gastroenterol. 2006;12(47):7666-70.
77. Su X, Matthay MA, Malik AB. Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsisinduced acute lung inflammatory injury. J Immunol. 2010;184(1): 401-10.
78. Shang GH, Lin DJ, Xiao W, et al. Ethyl pyruvate reduces mortality in an endotoxin-induced severe acute lung injury mouse model. Respir Res. 2009;10:91.
79. Gong Q, Xu JF, Yin H, Liu SF, Duan LH, Bian ZL. Protective effect of antagonist of high-mobility group box 1 on lipopolysaccharide-induced acute lung injury in mice. Scand J Immunol. 2009;69(1):29-35.
80. Gong Q, Yin H, Fang M, et al. Heme oxygenase-1 upregulation significantly inhibits TNF-[alpha] and Hmgb1 releasing and attenuates lipopolysaccharideinduced acute lung injury in mice. International Immunopharmacology. 2008;8(6):792-8.
81. Ueno H, Matsuda T, Hashimoto S, et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med. 2004;170(12):1310-16.
82. Ogawa EN, Ishizaka A, Tasaka S, et al. Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury. Am J Respir Crit Care Med. 2006;174(4):400-7.
83. Cohen MJ, Brohi K, Calfee CS, et al. Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care. 2009;13(6):R174.
84. Wheeler DS, Fisher LE Jr, Catravas JD, Jacobs BR, Carcillo JA, Wong HR. Extracellular hsp70 levels in children with septic shock. Pediatr Crit Care Med. 2005;6(3):308-11.
85. Chen T, Guo J, Han C, Yang M, Cao X. Heat Shock Protein 70, Released from Heat-Stressed Tumor Cells, Initiates Antitumor Immunity by Inducing Tumor Cell Chemokine Production and Activating Dendritic Cells via TLR4 Pathway. The Journal of Immunology. 2009;182(3): 1449-59.
86. Asea A, Rehli M, Kabingu E, et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem. 2002;277(17):15028-34.
87. Asea A, Kraeft SK, Kurt-Jones EA, et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 2000;6(4):435-42.
88. Ganter MT, Ware LB, Howard M, et al. Extracellular heat shock protein 72 is a marker of the stress protein response in acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2006;291(3):L354-61.
89. Pespeni M, Mackersie RC, Lee H, et al. Serum levels of Hsp60 correlate with the development of acute lung injury after trauma. J Surg Res. 2005; 126(1):41-7.
90. Vabulas RM, Ahmad-Nejad P, da CC, et al. Endocytosed HSP60 s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem. 2001; 276(33):31332-9.
91. Marechal X, Favory R, Joulin O, et al. Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock. 2008;29(5):572-6.
92. Chappell D, Hofmann-Kiefer K, Jacob M, et al. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol. 2009;104(1):78-89.
93. Nieuwdorp M, Meuwese MC, Mooij HL, et al. Tumor necrosis factor-[alpha] inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis. 2009;202(1):296-303.
94. Muto J, Yamasaki K, Taylor KR, Gallo RL. Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. Mol Immunol. 2009;47(2-3):449-56.
95. Martin TR, Hagimoto N, Nakamura M, Matute-Bello G. Apoptosis and epithelial injury in the lungs. Proc Am Thorac Soc. 2005;2(3):214-20.
96. Tang PS, Mura M, Seth R, Liu M. Acute lung injury and cell death: how many ways can cells die? Am J Physiol Lung Cell Mol Physiol. 2008;294(4):L632-41.
97. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000;165(6):2950-4.
98. Mascarenhas MM, Day RM, Ochoa CD, et al. Low molecular weight hyaluronan from stretched lung enhances interleukin-8 expression. Am J Respir Cell Mol Biol. 2004;30(1):51-60.
99. Bai KJ, Spicer AP, Mascarenhas MM, et al. The Role of Hyaluronan Synthase 3in Ventilator-induced Lung Injury. Am J Respir Crit Care Med. 2005;172(1):92-8.
100. Ren D, Sun R, Wang S. Role of inducible nitric oxide synthase expressed by alveolar macrophages in high mobility group box 1-induced acute lung injury. Inflamm Res. 2006;55(5):207-15.
101. Lin X, Yang H, Sakuragi T, et al. Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis. Am J Physiol Lung Cell Mol Physiol. 2005;289(4):L583-90.
102. Adair-Kirk TL, Atkinson JJ, Broekelmann TJ, et al. A site on laminin alpha 5, AQARSAASKVKVSMKF, induces inflammatory cell production of matrix metalloproteinase-9 and chemotaxis. J Immunol. 2003;171(1): 398-406.
103. Kolosova IA, Mirzapoiazova T, Moreno-Vinasco L, Sammani S, Garcia JGN, Verin AD. Protective effect of purinergic agonist ATP{gamma} S against acute lung injury. AJP-Lung Cellular and Molecular Physiology. 2008;294(2):L319-24.
104. Lucas R, Verin AD, Black SM, Catravas JD. Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem Pharmacol. 2009;77(12):1763-72.
105. Aymeric L, Apetoh L, Ghiringhelli F, et al. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res. 2010;70(3):855-8.
106. Ghiringhelli F, Apetoh L, Tesniere A, et al. Activation of the NLRP3inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med. 2009;15(10):1170-8.
107. Haitsma JJ, Uhlig S, Goggel R, Verbrugge SJ, Lachmann U, Lachmann B. Ventilator-induced lung injury leads to loss of alveolar and systemic compartmentalization of tumor necrosis factor-alpha. Intensive Care Med. 2000;26(10):1515-22.
108. Nakamura T, Fujiwara N, Sato E, et al. Effect of polymyxin B-immobilized fiber hemoperfusion on serum high mobility group box-1 protein levels and oxidative stress in patients with acute respiratory distress syndrome. ASAIO J. 2009;55(4):395-9.
109. Qing X, Pitashny M, Thomas DB, Barrat FJ, Hogarth MP, Putterman C. Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: Involvement of HMGB1in anti-DNA antibody-induced renal injury. Immunology Letters. 2008;121(1):61-73.
110. Wu H, Chen G, Wyburn KR, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest. 2007;117(10):2847-59.
111. Leemans JC, Stokman G, Claessen N, et al. Renal-associated TLR2mediates ischemia/reperfusion injury in the kidney. J Clin Invest. 2005;115(10): 2894-903.
112. Sappington PL, Yang R, Yang H, Tracey KJ, Delude RL, Fink MP. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology. 2002; 123(3):790-802.
113. Cheng BQ, Liu CT, Li WJ, et al. Ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis. Pancreas. 2007;35(3):256-61.
114. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005;294(10):1255-9.
115. Rahman I, MacNee W. Role of oxidants/antioxidants in smoking-induced lung diseases. Free Radical Biol Med. 1996;21(5):669-81.
116. Tuder RM, Yoshida T, Arap W, Pasqualini R, Petrache I. State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc. 2006;3(6):503-10.
117. Yoshida T, Mett I, Bhunia AK, et al. Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat Med. 2010 [Epub ahead of print].
118. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med. 2001;163(3):737-44.
119. Zheng T, Kang MJ, Crothers K, et al. Role of Cathepsin S-Dependent Epithelial Cell Apoptosis in IFN-g-Induced Alveolar Remodeling and Pulmonary Emphysema. J Immunol. 2005;174(12):8106-15.
120. Shapiro SD, Senior RM. Matrix metalloproteinases. Matrix degradation and more. Am J Resp Cell Mol Biol. 1999;20(6):1100-2.
121. MacNee W, Rahman I. Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? Trends Mol Med. 2001;7(2):55-62.
122. Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2007;37(6):748-55.
123. Rahman I, van Schadewijk AAM, Crowther AJL, et al. 4-Hydroxy-2Nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(4):490-5.
124. Deslee G, Woods JC, Moore C, et al. Oxidative damage to nucleic acids in severe emphysema. Chest. 2009;135(4):965-74.
125. Rahman I, Biswas SK, Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol. 2006;533(1-3):222-39.
126. Tuder RM, Zhen L, Cho CY, et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol. 2003;29(1):88-97.
127. Petrache I, Natarajan V, Zhen L, et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med. 2005;11(5):491-8.
128. Giordano RJ, Lahdenranta J, Zhen L, et al. Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse. J Biol Chem. 2008;283(43):29447-60.
129. Sussan TE, Rangasamy T, Blake DJ, et al. Targeting Nrf2 with the t{stroke}riterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proc Natl Acad Sci U S A. 2009;106(1):250-5.
130. Ricci JE, Gottlieb RA, Green DR. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J Cell Biol. 2003;160(1):65-75.
131. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA. Induction of immunological tolerance by apoptotic cells requires caspasedependent oxidation of high-mobility group box-1 protein. Immunity. 2008;29(1):21-32.
132. Klamt F, Zdanov S, Levine RL, et al. Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin. Nat Cell Biol. 2009;11(10):1241-6.
133. Sixt SU, Adamzik M, Spyrka D, et al. Alveolar extracellular 20 S proteasome in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2009;179(12):1098-106.
134. Kelsen SG, Duan X, Ji R, Perez O, Liu C, Merali S. Cigarette smoke induces an unfolded protein response in the human lung: a proteomic approach. Am J Respir Cell Mol Biol. 2008;38(5):541-50.
135. Malhotra D, Thimmulappa R, Vij N, et al. Heightened endoplasmic reticulum stress in COPD lungs: The role of Nrf2-regulated proteasomal activity. Am J Respir Crit Care Med. 2009; 200903-0324OC.
136. Weathington NM, van Houwelingen AH, Noerager BD, et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med. 2006;12(3):317-23.
137. Huszar E, Vass G, Vizi E, et al. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J. 2002;20(6):1393-8.
138. Mortaz E, Braber S, Nazary M, Givi ME, Nijkamp FP, Folkerts G. ATP in the pathogenesis of lung emphysema. Eur J Pharmacol. 2009;619(1-3): 92-6.
139. Kang MJ, Lee CG, Lee JY, et al. Cigarette smoke selectively enhances viral PAMP and viruses-induced pulmonary innate immunity and remodeling responses. J Clin Invest. 2008;118(8):2771-84.
140. Agusti A, MacNee W, Donaldson K, Cosio M. Hypothesis: does COPD have an autoimmune component? Thorax. 2003;58(10):832-34.
141. + T Cells in the Lungs of Patients with Severe Emphysema. Am J Respir Crit Care Med. 2005;172(5):590-6.
142. Feghali-Bostwick CA, Gadgil AS, Otterbein LE, et al. Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(2):156-63.
143. Grumelli S, Corry DB, Song LZ, et al. An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and Emphysema. PLoS Medicine. 2004;1(1):e8.
144. Hall JC, Casciola-Rosen L, Rosen A. Altered structure of autoantigens during apoptosis. Rheum Dis Clin North Am. 2004;30(3):455-71.
145. Levine SM, Raben N, Xie D, et al. Novel conformation of histidylt{stroke}ransfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibodyassociated myositis. Arthritis Rheum. 2007;56(8):2729-39.
146. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol. 2008;8(4):279-89.
147. Chang MK, Binder CJ, Miller YI, et al. Apoptotic cells with oxidationspecific epitopes are immunogenic and proinflammatory. J Exp Med. 2004; 200(11):1359-70.
148. Agusti AG, Sauleda J, Miralles C, et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(4):485-9.
149. Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(4):367-70.
150. Vandivier RW, Fadok VA, Hoffmann PR, et al. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest. 2002;109(5):661-70.
151. Richens TR, Linderman DJ, Horstmann SA, et al. Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. Am J Respir Crit Care Med. 2009;179(11):1011-21.
152. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994;12:991-1045.